An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

The Global Library of Women’s Medicine
Clinical guidance and resources

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

1000+ OBGYN Project Resources

Ovarian Cancer – Basic Science Perspective

Chapter 1 - Epidemiology and Etiology of Ovarian Cancer

Chapter 2 - Inflammation and Ovarian Cancer

Chapter 3 - Photonic Sensor System for Screening Serum Biomarker Proteins in Ovarian Cancer

Chapter 4 - The Role of MUC16 Mucin (CA125) in the Pathogenesis of Ovarian Cancer

Chapter 5 - Apoptosis Pathways in Ovarian Cancer

Chapter 6 - Oncogenic Pathway Signatures and Survival Outcome

Chapter 7 - Dysregulated TGF – Signaling in Ovarian Cancer

Chapter 8 - New Tumor Biomarkers in Ovarian Cancer and Its Prognostic and Clinical Relevance

Chapter 9 - Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy

Chapter 10 - Homeobox Genes and Their Functional Significance in Ovarian Tumorigenesis

Chapter 11 - Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation

Chapter 12 - Potential Tumor Biomarkers for Ovarian Cancer

Chapter 13 - Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets

Chapter 14 - P53 Network in Ovarian Cancer

Chapter 15 - Gene Amplification in Ovarian Carcinomas: Lessons from Selected Amplified Gene Families

Chapter 16 - Nitric Oxide/Protein Kinase G-I? Promotes c-Src Activation, Proliferation and Chemoresistance in Ovarian Cancer

Chapter 17 - VEGF Targeting Agents in Ovarian Cancer

Chapter 18 - Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?

Chapter 19 - Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer